×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Implied Volatility Surging for Kadmon Holdings (KDMN) Stock Options
Yahoo News New Zealand
Investors need to pay close attention to Kadmon Holdings (KDMN) stock based on the movements in the options market lately.
3 days ago
Sanofi to acquire Kadmon to further strengthen growth of transplant business
GlobeNewswire
Sanofi to acquire Kadmon to further strengthen growth of transplant business Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class...
31 months ago
Sanofi Closes NY Kadmon Facility in Effort to Simplify Operations
BioSpace
Six months after acquiring Kadmon Holdings, pharma giant Sanofi is closing Kadmon's New York facility. As part of the paring down, Sanofi is...
24 months ago
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal
Reuters
French drugmaker Sanofi said on Wednesday it would buy U.S. biopharmaceutical company Kadmon Holdings for 1.9 billion dollars,...
31 months ago
Play-by-play: How Sanofi jacked up its offer twice to seal the $1.9B deal for Kadmon
Fierce Pharma
With an existing transplant portfolio, Sanofi is naturally fit to be the new owner of Kadmon, developer of graft-versus-host disease (GVHD)...
31 months ago
Kadmon Stock Soars as Sanofi Buys U.S. Biotech for $1.9 Billion
Barron's
Shares of Kadmon Holdings were soaring Wednesday after French drugmaker Sanofi said it was buying the U.S. biopharmaceutical company for...
31 months ago
Sanofi To Acquire Kadmon In $1.9B Deal
Contract Pharma
Adds Rezurock, a recently FDA-approved first-in-class treatment for chronic graft-versus-host disease (cGVHD)
32 months ago
Like a ROCK: Sanofi takes out Kadmon for $1.9B, gains transplant drug
BioCentury
Kadmon's decade-long commitment to developing ROCK inhibitors has culminated in a $1.9 billion takeout by Sanofi, less than two months after...
31 months ago
KDMN Stock: 6 Things to Know About Biopharma Kadmon Holdings as Shares Skyrocket
InvestorPlace
Kadmon Holdings (KDMN) stock is rising higher on Wednesday following news of a deal with Sanofi (SNY) that comes to $1.9 billion.
31 months ago
Sam Waksal's Kadmon Holdings shares open below offering price in debut
CNBC
Sam Waksal's Kadmon Holdings shares opened at $11.55 in their Wednesday debut, below the initial public offering price of $12 per share.
93 months ago